Carsten Brunn | President and Chief Executive Officer |
Kevin Tan | Chief Financial Officer |
Peter Traber | Chief Medical Officer |
Takashi Kishimoto | Chief Scientific Officer |
Elizabeth Scott | SVB Securities |
Rick Miller | Cantor Fitzgerald |
Yun Zhong | BTIG |
John Newman | Canaccord |
Tiffany Marchell | William Blair |
Boobalan Pachaiyappan | H.C. Wainwright |
Uy Ear | Mizuho |
Good morning, and welcome to the Selecta Biosciences Third Quarter 2022 Financial Results and Business Update Conference Call. [Operator Instructions] This call is being webcast live on the Investor and Media section of Selecta's website at www.selectabio.com and is being recorded.
For opening remarks, I would like to introduce you, Mr. Kevin Tan, Chief Financial Officer of Selecta. Please go ahead, sir.